Table 2. Effect of mycophenolate mofetil on modified Rodnan skin score.
Author | Duration of Therapy (months) | Mean baseline MRSS | Median baseline MRSS | MRSS at end of study | Level of significance |
---|---|---|---|---|---|
Stratton et al.[19] | 12 | 28 | NA | 17 | p < 0.001 |
Vanthuyne et al.[25] | 12 | 20 | NA | 13 | p < 0.0001 for all patients p = 0.002 for skin group |
Nihtyanova et al.[27] | 60 | NA | 26 | 11 | NA |
Le et al.[31] | 12 | 24.4 | NA | 17.5 | p < 0.001 |
Mendoza et al.[20] | Mean 18.2 | 24.56 | NA | 14.5 | p = 0.0004 |
Derk et al.[21] | 12 | 22.5 | 21.5 | 8.4 | p < 0.0001 |
Koutroumpas et al.[29] | 12 | 17.2 | NA | 17.7 | p = 0.55 |
Herrick et al.[23] | p = 0.43 | ||||
Protocol 1 | 36 | NA | 24 | NA | –1.81 (95%CI—4.08, 0.460) |
Protocol 2 | 36 | NA | 32 | NA | –4.46 (95%CI—6.69, –2.23) |
Protocol 3 | 36 | NA | 23.5 | NA | –3.10 (95%CI—4.27, –1.93) |